KAREM SAUND: Open Payments
NPI 1679169890 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,833 in 153 payments from 19 companies in 2025. Trend: 2023 $778 · 2024 $1,432 · 2025 $3,833
Food & beverage: $3,647Education: $186
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 32 | $668 |
| ABBVIE INC. | 24 | $443 |
| Organon LLC | 13 | $385 |
| Incyte Corporation | 12 | $317 |
| Janssen Biotech, Inc. | 8 | $269 |
| Amgen Inc. | 11 | $247 |
| GENZYME CORPORATION | 12 | $245 |
| Lilly USA, LLC | 6 | $244 |
| Regeneron Healthcare Solutions, Inc. | 9 | $229 |
| Galderma Laboratories, L.P. | 5 | $213 |
Products named: DUPIXENT, ADBRY, VTAMA, OPZELURA, ANZUPGO, TREMFYA, SKYRIZI, Otezla.
Industry payments across VA — which companies pay providers there.
